» Articles » PMID: 37490289

Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden

Overview
Journal JAMA Netw Open
Specialty General Medicine
Date 2023 Jul 25
PMID 37490289
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Neurocutaneous syndromes are associated with cancer predisposition and sometimes associated with perinatal factors. A better understanding of the association between neurocutaneous syndromes, perinatal factors, and childhood cancer is key for earlier cancer detection.

Objective: To evaluate the association of neurocutaneous syndromes and perinatal factors with childhood cancer risk in a cohort of Swedish children.

Design, Setting, And Participants: In this nationwide cohort study, all children and adolescents up to age 20 years, from 1973 to 2015, were identified through the Swedish National Medical Birth Register (MBR), provided they had information on both biological parents. Analyses were conducted from April 2021 through May 2023.

Exposures: Diagnoses of neurocutaneous syndromes were obtained from the MBR, National Patient Register, and Cause of Death register. Perinatal factors (birth weight, gestational age, birth weight by gestational age, 5-minute Apgar score, and head circumference) were obtained from the MBR.

Main Outcomes And Measures: Childhood cancer risk (<20 years at diagnosis; identified from the National Cancer Register), including leukemia, lymphoma, and central nervous system (CNS) tumors.

Results: Among 4 173 108 included children (2 143 133 [51.4%] male, median [IQR] follow-up 20 [9.7-20] years), 1783 had neurofibromatosis type 1 (NF1), 444 tuberous sclerosis, 63 von Hippel-Lindau disease, and 39 ataxia-telangiectasia. An increased cancer risk was observed among children with any neurocutaneous syndrome (HR, 34.9; 95% CI, 30.8-39.6) and was particularly pronounced for CNS tumors (HR, 111.7; 95% CI, 96.8-128.8), except among children with ataxia-telangiectasia, where the increased risk was associated with lymphomas (HR, 233.1; 95% CI, 75.0-724.1). Leukemia risk was increased only among children with NF1 (HR, 4.1; 95% CI, 1.7-9.8). Several perinatal factors, including high birth weight, being born large for gestational age, preterm birth, low 5-minute Apgar score, and large head circumference had lesser associations with childhood cancer. Adjusting for neurocutaneous syndromes did not affect these associations.

Conclusions And Relevance: In this nationwide cohort study, neurocutaneous syndromes were associated with an increased risk of childhood cancer, especially CNS tumors. Several perinatal factors had lesser associations with childhood cancer, independently of the presence of neurocutaneous syndromes. Other biological mechanisms likely underlie the association between perinatal factors and childhood cancer.

Citing Articles

The contribution of low Apgar scores in identifying neonates with short-term morbidities in a large single center cohort.

Huang S, Yitayew M, Rozycki H J Perinatol. 2024; 44(6):865-872.

PMID: 38548866 PMC: 11161404. DOI: 10.1038/s41372-024-01944-0.

References
1.
Schmidt L, Schuz J, Lahteenmaki P, Trager C, Stokland T, Gustafson G . Fetal growth, preterm birth, neonatal stress and risk for CNS tumors in children: a Nordic population- and register-based case-control study. Cancer Epidemiol Biomarkers Prev. 2010; 19(4):1042-52. DOI: 10.1158/1055-9965.EPI-09-1273. View

2.
Sur M, Armat I, Sur G, Pop D, Samasca G, Lupan I . Neurofibromatosis in Children: Actually and Perspectives. Children (Basel). 2022; 9(1). PMC: 8774615. DOI: 10.3390/children9010040. View

3.
Barlow L, Westergren K, Holmberg L, Talback M . The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2008; 48(1):27-33. DOI: 10.1080/02841860802247664. View

4.
Walker L, Thompson D, Easton D, Ponder B, Ponder M, Frayling I . A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer. 2006; 95(2):233-8. PMC: 2360616. DOI: 10.1038/sj.bjc.6603227. View

5.
Ullrich N . Neurocutaneous Syndromes and Brain Tumors. J Child Neurol. 2015; 31(12):1399-411. DOI: 10.1177/0883073815604220. View